E. B. D. Araújo, Tatiana Lavinas, Maria Tereza Colturato, Jair Mengatti
{"title":"Garantia da qualidade aplicada à produção de radiofármacos","authors":"E. B. D. Araújo, Tatiana Lavinas, Maria Tereza Colturato, Jair Mengatti","doi":"10.1590/S1516-93322008000100002","DOIUrl":null,"url":null,"abstract":"Radiopharmaceuticals have been produced and distributed in Brazil for almost 40 years, by the Institutes of the Comissao Nacional de Energia Nuclear (CNEN) particularly the Instituto de Pesquisas Energeticas e Nucleares (IPEN), and applied in Nuclear Medicine in diagnostic and therapeutic procedures. Some aspects related to the production, distribution and use of radiopharmaceuticals are very uncommon and different from the conventional drugs, making necessary the introduction of an specific regulation for these radioactive drugs. In this way, the World Health Organization (WHO) and health regulatory agencies from different countries have specific legislations to radiopharmaceuticals production and use.","PeriodicalId":21193,"journal":{"name":"Revista Brasileira De Ciencias Farmaceuticas","volume":"19 1","pages":"1-12"},"PeriodicalIF":0.0000,"publicationDate":"2008-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Brasileira De Ciencias Farmaceuticas","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/S1516-93322008000100002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11
Abstract
Radiopharmaceuticals have been produced and distributed in Brazil for almost 40 years, by the Institutes of the Comissao Nacional de Energia Nuclear (CNEN) particularly the Instituto de Pesquisas Energeticas e Nucleares (IPEN), and applied in Nuclear Medicine in diagnostic and therapeutic procedures. Some aspects related to the production, distribution and use of radiopharmaceuticals are very uncommon and different from the conventional drugs, making necessary the introduction of an specific regulation for these radioactive drugs. In this way, the World Health Organization (WHO) and health regulatory agencies from different countries have specific legislations to radiopharmaceuticals production and use.